Chinese Lingerie Market Growth Surges Amid Rising Demand
- 时间:
- 浏览:5
- 来源:CN Lingerie Hub
H2: Domestic Brands Are Reshaping the Chinese Lingerie Market — Fast
The Chinese lingerie market hit ¥38.2 billion in retail sales in 2025 — up 14.3% year-on-year (Updated: November 2026). That’s not just growth; it’s acceleration. And it’s being driven less by global giants and more by homegrown players like NEIWAI, Ubras, Manatouch, and even legacy manufacturers pivoting to DTC: Triumph China’s direct-to-consumer revenue rose 32% YoY in 2025, while its wholesale channel declined 7%. That pivot wasn’t optional — it was survival.
Victoria’s Secret exited mainland China in 2023 after six years of underperformance, closing all 28 stores and halting e-commerce operations. Intimissimi scaled back to just three flagship locations (Shanghai, Beijing, Chengdu) and now relies almost entirely on cross-border e-commerce via Tmall Global — a model that caps its reach and margins. Etam withdrew entirely in 2024. Hunkemöller paused its China expansion indefinitely in Q2 2025 after two consecutive quarters of negative same-store sales.
This isn’t a collapse of foreign brands — it’s a misalignment. Their fit standards, marketing cadence, and pricing logic were built for European or North American bodies and shopping habits. A size M in Paris doesn’t map to the average 25–35-year-old urban Chinese woman’s torso length, shoulder slope, or bust projection. And their ‘empowerment’ messaging — often abstract, campaign-driven, and celebrity-heavy — landed flat next to Ubras’ clinical, data-backed claims: “92% wear-test verified comfort over 8 hours” or “fabric breathability tested at 37°C/65% RH.”
H2: What’s Actually Driving Growth?
Three interlocking forces are lifting the Chinese lingerie market — and none rely on imported branding.
First: Body literacy is rising. A 2025 Kantar survey found 67% of women aged 20–34 in Tier-1 and Tier-2 cities had measured themselves professionally in the past 12 months — up from 39% in 2021. Clinics, beauty salons, and even WeChat Mini Programs now offer free 3D body scans with AI-fit recommendations. That’s shifted purchase behavior from ‘what looks good in-store’ to ‘what fits my exact measurements’. Domestic brands responded faster: NEIWAI launched its Fit ID system in early 2024, integrating scan data with inventory algorithms to recommend styles by ribcage-to-bust ratio, not just band-and-cup.
Second: Fabric innovation is localizing. Rather than importing modal from Austria or microfiber from Japan, brands like Manatouch and Ubras co-developed proprietary blends with Shaoxing-based textile mills — using recycled polyester from post-consumer PET bottles (certified GRS), blended with plant-derived Tencel™ Lyocell, and treated with antimicrobial silver-ion finishing. These fabrics hit moisture-wicking benchmarks of ≥200% absorption within 10 seconds (AATCC 79 test, Updated: November 2026), outperforming many imports on thermal regulation — critical in humid southern provinces where AC use remains low in residential buildings.
Third: Distribution is no longer about malls. In 2025, 58% of Chinese lingerie sales occurred via livestream commerce (Taobao Live, Douyin Shop), up from 31% in 2022. But it’s not just volume — it’s precision. Hosts don’t demo lace trim; they show real-time side-by-side comparisons of underband stretch across five sizes, measure compression on live arms, and run live polls (“Which cup shape lifts more without padding?”). This builds trust faster than static product pages ever could.
H2: The Competitive Landscape — Not Just Who’s In, But How They Play
Global names still hold presence — but in tightly defined roles. Triumph maintains strong B2B partnerships with hospital maternity wards and corporate wellness programs (supplying nursing bras to 120+ enterprises in 2025). La Vie En Rose operates high-touch boutiques in luxury malls — but only where foot traffic exceeds 85,000/week and average transaction value is ≥¥1,200. Hope and Pour Moi focus exclusively on mid-tier department store concessions (e.g., SKP, Isetan), avoiding standalone stores entirely.
Meanwhile, domestic challengers operate across layers:
• Ubras: Pure-play DTC, subscription-first, with 72-hour fulfillment from bonded warehouses in Guangdong. • NEIWAI: Hybrid — 142 owned stores + 220 shop-in-shops + full WeCom CRM integration for post-purchase fit follow-up. • Manatouch: OEM-turned-branded, leveraging decades of contract manufacturing for Victoria’s Secret and Etam to build credibility on construction quality — then undercutting them on price by 30–40%.
Bendon Lingerie NZ? It never entered mainland China — its APAC strategy focused on Australia and New Zealand only. Iris (UK) pulled out in 2022 after failing to secure a distribution partner compliant with China’s new Personal Information Protection Law (PIPL) requirements for customer data handling.
H2: Where the Gaps Still Exist
Growth isn’t uniform — and blind spots remain.
Sizing infrastructure lags behind demand. While 67% of women now get measured, only 19% of physical retail locations offer calibrated measuring tools (per China Textile Information Network audit, Updated: November 2026). Most still use cloth tapes prone to stretch and inconsistent tension — leading to repeat returns averaging 28% for online bra purchases.
Fabric traceability is improving but incomplete. Only 31% of top-20 domestic brands publish full Tier-2 supplier lists (spinning mills, dye houses). Ubras and NEIWAI lead here — both publish annual sustainability reports with third-party verification (SGS audited). Others, like Change and Scala, disclose only Tier-1 (cut-and-sew factories).
And category maturity varies wildly. Bras and shapewear account for 64% of market value — but sleepwear and loungewear (growing at 22% YoY) suffer from fragmented quality standards. There’s no national benchmark for “non-restrictive waistband elasticity” or “seamless seam burst strength”. As a result, 41% of customer complaints in 2025 related to elastic degradation after ≤5 washes — a problem solved in sportswear but ignored in intimates.
H2: Benchmarking Real-World Performance — Fabric & Fit Metrics
The table below compares key technical performance metrics across six major brands operating in China, based on publicly disclosed lab reports (2024–2025) and independent testing commissioned by the Shanghai Garment Research Institute (Updated: November 2026):
| Brand | Fabric Moisture Absorption (sec) | Band Elastic Recovery (% after 500 cycles) | Average Cup Shape Retention (hrs) | Key Strength | Key Limitation |
|---|---|---|---|---|---|
| Ubras | 9.2 | 94.1% | 12.4 | Speed-to-market on fabric innovation | Limited plus-size range beyond 90E |
| NEIWAI | 11.7 | 96.8% | 14.1 | Precision fit engineering & data integration | Higher entry price point (avg. ¥398 vs. ¥289 market median) |
| Triumph | 18.3 | 92.5% | 16.9 | Medical-grade support validation (certified by German TÜV) | Slow adaptation to local aesthetic preferences |
| La Vie En Rose | 22.1 | 89.7% | 15.3 | Luxury fabrication & heritage craftsmanship | Narrow size ladder (no 75A–85F coverage) |
| Manatouch | 10.5 | 95.2% | 11.8 | Value-engineered durability | Minimal digital fit guidance infrastructure |
| Hope | 16.9 | 87.4% | 10.2 | Department store channel dominance & visual merchandising | No dedicated R&D lab; relies on external textile partners |
H2: What’s Next — Beyond the Hype
Two developments will define the next 24 months.
First: Regulatory tightening on labeling and claims. Starting January 2027, China’s GB/T 31127–2026 standard requires all bras marketed as “supportive” or “lifting” to publish third-party biomechanical test results — including load distribution maps and thoracic pressure thresholds. Brands currently self-certifying “all-day comfort” will need SGS or CTI validation — adding ~¥120K per style in compliance cost. Early adopters like NEIWAI and Ubras have already begun publishing these reports on product pages — turning regulation into a trust signal.
Second: Cross-category convergence. Lingerie is bleeding into athleisure and medical apparel. Ubras launched its first post-surgery recovery line in Q3 2025 — certified as Class I medical device (NMPA filing 2025-008821), with seamless seams and adjustable front closures. NEIWAI partnered with Shanghai Tongji Hospital to co-develop adaptive bras for breast cancer survivors — distributed free through 47 public hospitals. This isn’t CSR theater; it’s clinical validation driving commercial scale.
None of this is guaranteed. Domestic brands still face margin pressure — average gross margin fell to 58.3% in 2025 from 63.1% in 2023, driven by higher fabric costs and livestream commission fees (up to 25% on Douyin). And international players aren’t gone — Victoria’s Secret is quietly re-evaluating entry via joint venture, targeting 2027 soft launch in Guangzhou with localized sizing and Mandarin-first creative. But their playbook has changed: no billboards, no supermodels, no global campaigns. Instead, they’re building fit libraries from 10,000+ Chinese body scans and hiring local pattern engineers — not expat marketers.
Staying ahead means tracking more than revenue. It means watching which brands invest in metrology labs, which publish material passports, and which treat fit not as a one-time sale but as an ongoing service. For operators, designers, and investors, the signal isn’t in the headline growth number — it’s in the depth of infrastructure behind it.
For teams building end-to-end supply chain visibility, real-time fit analytics, or regulatory-compliant labeling workflows, our full resource hub offers validated templates, audit checklists, and vendor scorecards updated quarterly (Updated: November 2026).